Project Details
Description
A Phase 2 Pan-tumor, Open-label Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects with Recurrent or Metastatic Solid Tumors (IDeate-5)
| Status | Active |
|---|---|
| Effective start/end date | 7/10/24 → 7/9/35 |
Funding
- DAIICHI SANKYO, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.